Management of Osteoarthritis with Meloxicam 15 mg

Medication Management for Meloxicam

The British Medical Journal recommends taking Meloxicam at the lowest effective dose (15 mg is the maximum recommended daily dose) for the shortest possible period to minimize risks 1
The British Medical Journal suggests monitoring for potential renal effects, especially in elderly patients or those with kidney disease 1

The British Medical Journal advises informing your healthcare provider about any medical conditions, especially history of gastrointestinal bleeding or ulcers, cardiovascular disease or hypertension, and kidney disease 1
The British Medical Journal recommends considering gastroprotection with a proton pump inhibitor if at high risk for gastrointestinal complications 1
The British Medical Journal suggests avoiding concurrent use with other NSAIDs and low-dose aspirin 1

The American College of Sports Medicine recommends regular exercise, including strengthening exercises for muscles around affected joints, low-impact aerobic activities, and aiming for at least 30 minutes of activity most days of the week, as stated in Praxis Medical Insights 2
The National Institute of Diabetes and Digestive and Kidney Diseases recommends weight management, with even modest weight loss (5-10% of body weight) significantly reducing joint pain, as stated in Praxis Medical Insights 2

The British Medical Journal recommends applying local heat or cold for temporary pain relief 4
The American Physical Therapy Association suggests considering physical therapy for personalized exercise programs and manual therapy, as stated in Praxis Medical Insights 2

The British Medical Journal advises scheduling regular follow-up appointments to assess treatment effectiveness 4
The British Medical Journal recommends discussing the need for periodic blood tests to monitor kidney and liver function 1
The American Academy of Orthopaedic Surgeons suggests considering surgical options if symptoms substantially affect quality of life despite comprehensive treatment, as stated in the British Medical Journal 4